
EMA recommends marketing authorization for donanemab (Kisunla)
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
This announcement reverses an earlier recommendation made by the EMA regarding donanemab as a treatment for the treatment of early symptomatic Alzheimer's disease in adults.
The 78th World Health Assembly has been a whirlwind week for ADI as, after 18-months of advocacy, the World Health Assembly has agreed to extend the Global Action Plan on the Public Health Response to Dementia by 6-years, to 2031.
Ahead of the G20 Health Ministers Meeting in Okayama, ADI’s Chief Executive Paola Barbarino and Noriyo Washizu of Alzheimer's Association Japan (AAJ) continue to work on progress made earlier in the year at the Osaka Summit.
Ahead of the G20 Health Ministers Meeting in Okayama, ADI Chief Executive Paola was interviewed by one of Japan's largest newspaper.
The Spanish Ministry of Health, Consumption and Social Welfare has announced that they have adopted a national dementia plan.
New Zealand's Dementia Declaration is the result of people affected by dementia getting together and identifying what they need to live well.
Results from the world’s largest survey reveals that stigma around dementia is preventing people from seeking the information, advice, support and medical help.
Alzheimer’s Disease International (ADI) and the Pan American Health Organization (PAHO) launch an Americas-wide campaign around raising awareness of Alzheimer's disease and other types of dementia.
Dementia was specifically recognised as a global health priority by G20 leaders in the declaration of the Osaka Summit, providing much needed global attention from G20 countries.
The Canadian government has announced their adoption of a national plan on dementia.